Australia & New Zealand Fertility Services Market by Procedure (IVF with ICSI, IUI, IVF without ICSI, Surrogacy, and Others), Service (Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor, and Frozen Donor), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Opportunity Analysis and Industry Forecast, 2019–2026

August 2019 | 104 pages | ID: A20F82FAA7B7EN
Allied Market Research

Abstracts

The Australia & New Zealand fertility services market generated $709 million in 2018, and is projected to reach $1,020 million by 2026, growing at a CAGR of 4.6% from 2019 to 2026.

Fertility services are treatments that assist in treating infertility in patients. In vitro fertilization (IVF), surrogacy, intrauterine insemination, and others are different forms of infertility services that help single mothers, couples with infertility problems, and people from the LGBT community to procreate.

The Australia & New Zealand fertility services market is expected to witness a substantial growth in the future, owing to higher number of infertility cases, emerging trend of delayed pregnancies among women, rise in technological advancements in fertility procedures, and large presence of fertility clinics with trained medical professionals. In addition, availability of advanced fertility treatments, increase in disposable income, and favorable reimbursement policies further augment the market growth in Australia & New Zealand. In addition, recent innovations in IVF technology with surge in assisted reproductive technology (ART) success rate are projected to boost the demand for fertility services in the future. However, higher cost, complications associated with ART treatment, and multiple pregnancies associated with fertility treatments are projected to hinder the market growth. Rise in new fertility clinics and increase in same-sex marriages are projected to offer lucrative growth opportunities in future.

The Australia & New Zealand fertility services market is segmented based on procedure, service, and end user. Based on procedure, the market is divided into IVF with intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), IVF without ICSI, surrogacy, and others. Based on service, it is categorized into fresh non-donor, frozen non-donor, egg and embryo banking, fresh donor, and frozen donor. Based on end user, the market is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of all the regions is provided to determine the existing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Procedure

• IVF with ICSI
• IUI
• IVF without ICSI
• Surrogacy
• Others

Service

• Fresh Non-donor
• Frozen Non-donor
• Egg and Embryo Banking
• Fresh Donor
• Frozen Donor

End User

• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes

LIST of KEY PLAYERS PRofILED IN THE REPORT

• Adora Fertility
• Care Fertility
• City Fertility
• Fertility Associates Limited
• Fertility First
• Fertility SA
• GENEA LIMITED
• Monash IVF Group Limited
• National Women’s Health
• Virtus Health

LIST of OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

• Demeter Fertility
• Coastal IVF
• Melbourne IVF

Contents

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
  1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
  1.4.1. Secondary Research
  1.4.2. Primary Research
  1.4.3. Analyst Tools And Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key Findings of The Study
2.2. Cxo Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition And Scope
3.2. Key Findings
  3.2.1. Top Investment Pockets
  3.2.2. Market Player Positioning, 2018
3.3. Porter’S Five Force Analysis
3.4. Market Dynamics
  3.4.1. Drivers
    3.4.1.1. Continuous Decline In Fertility Rates
    3.4.1.2. Delayed Pregnancies In Women
    3.4.1.3. Technological Advancements With Respect To Fertility Treatment
  3.4.2. Restraint
    3.4.2.1. High Treatment Costs of Arts
  3.4.3. Opportunity
    3.4.3.1. Rise In Adoption of Assisted Reproductive Technology In Australia & New Zealand
  3.4.4. Impact Analysis

CHAPTER 4: AUSTRALIA & NEW ZEALAND FERTILITY SERVICES MARKET, BY PROCEDURE

4.1. Overview
  4.1.1. Market Size And Forecast, By Type
4.2. Ivf With Icsi
  4.2.1. Key Market Trends And Opportunities
  4.2.2. Market Size And Forecast
4.3. Iui
  4.3.1. Key Market Trends And Opportunities
  4.3.2. Market Size And Forecast
4.4. Ivf Without Icsi
  4.4.1. Key Market Trends And Opportunities
  4.4.2. Market Size And Forecast
4.5. Surrogacy
  4.5.1. Key Market Trends And Opportunities
  4.5.2. Market Size And Forecast
4.6. Others
  4.6.1. Key Market Trends And Opportunities
  4.6.2. Market Size And Forecast

CHAPTER 5: AUSTRALIA & NEW ZEALAND FERTILITY SERVICES MARKET, BY SERVICE

5.1. Overview
  5.1.1. Market Size And Forecast, By Service
5.2. Fresh Non-Donor
  5.2.1. Market Size And Forecast
5.3. Frozen Non-Donor
  5.3.1. Market Size And Forecast
5.4. Egg And Embryo Banking
  5.4.1. Market Size And Forecast
5.5. Fresh Donor
  5.5.1. Market Size And Forecast
5.6. Frozen Donor
  5.6.1. Market Size And Forecast

CHAPTER 6: AUSTRALIA & NEW ZEALAND FERTILITY SERVICES MARKET, BY END USER

6.1. Overview
  6.1.1. Market Size And Forecast, By Type
6.2. Fertility Clinics
  6.2.1. Market Size And Forecast
6.3. Hospitals
  6.3.1. Market Size And Forecast
6.4. Surgical Centers
  6.4.1. Market Size And Forecast
6.5. Clinical Research Institutes
  6.5.1. Market Size And Forecast

CHAPTER 7: COMPANY PROFILES

7.1. Adora Fertility
  7.1.1. Company Overview
  7.1.2. Company Snapshot
  7.1.3. Operating Business Segments
  7.1.4. Product Portfolio
7.2. Care Fertility
  7.2.1. Company Overview
  7.2.2. Company Snapshot
  7.2.3. Operating Business Segments
  7.2.4. Product Portfolio
7.3. City Fertility
  7.3.1. Company Overview
  7.3.2. Company Snapshot
  7.3.3. Operating Business Segments
  7.3.4. Product Portfolio
  7.3.5. Key Strategic Moves And Developments
7.4. Fertility Associates Limited
  7.4.1. Company Overview
  7.4.2. Company Snapshot
  7.4.3. Operating Business Segments
  7.4.4. Product Portfolio
7.5. Fertility First
  7.5.1. Company Overview
  7.5.2. Company Snapshot
  7.5.3. Operating Business Segments
  7.5.4. Product Portfolio
7.6. Fertility Sa
  7.6.1. Company Overview
  7.6.2. Company Snapshot
  7.6.3. Operating Business Segments
  7.6.4. Product Portfolio
7.7. Genea Limited
  7.7.1. Company Overview
  7.7.2. Company Snapshot
  7.7.3. Operating Business Segments
  7.7.4. Product Portfolio
  7.7.5. Key Strategic Moves And Developments
7.8. Monash Ivf Group Limited
  7.8.1. Company Overview
  7.8.2. Company Snapshot
  7.8.3. Operating Business Segments
  7.8.4. Product Portfolio
  7.8.5. Business Performance
  7.8.6. Key Strategic Moves And Developments
7.9. National Women’S Health
  7.9.1. Company Overview
  7.9.2. Company Snapshot
  7.9.3. Operating Business Segments
  7.9.4. Product Portfolio
7.10. Virtus Health
  7.10.1. Company Overview
  7.10.2. Company Snapshot
  7.10.3. Operating Business Segments
  7.10.4. Product Portfolio
  7.10.5. Business Performance

List Of Tables

LIST OF TABLES

Table 01. Australia & New Zealand Fertility Services Market, By Procedure, 2018–2026 ($Million)
Table 02. Australia & New Zealand Fertility Services Market, By Service, 2018–2026 ($Million)
Table 03. Australia & New Zealand Fertility Services Market, By End User, 2018–2026 ($Million)
Table 04. Adora Fertility: Company Snapshot
Table 05. Adora Fertility: Product Portfolio
Table 06. Care Fertility: Company Snapshot
Table 07. Care Fertility: Product Portfolio
Table 08. City Fertility: Company Snapshot
Table 09. City Fertility: Product Portfolio
Table 10. Fertility Associates: Company Snapshot
Table 11. Fertility Associates: Operating Segments
Table 12. Fertility Associates: Product Portfolio
Table 13. Fertility First: Company Snapshot
Table 14. Fertility First: Product Portfolio
Table 15. Fertility Sa: Company Snapshot
Table 16. Fertility Sa: Product Portfolio
Table 17. Genea Limited: Company Snapshot
Table 18. Genea Limited: Operating Segments
Table 19. Genea Limited: Service Portfolio
Table 20. Mvf: Company Snapshot
Table 21. Mvf: Product Portfolio
Table 22. Nwh: Company Snapshot
Table 23. Nwh: Operating Segments
Table 24. Nwh: Product Portfolio
Table 25. Virtus Health: Company Snapshot
Table 26. Virtus Health: Operating Segments
Table 27. Virtus Health: Product Portfolio

List Of Figures

LIST OF FIGURES

Figure 01. Australia & New Zealand Fertility Services Market Segmentation
Figure 02. Top Investment Pockets
Figure 03. Market Player Positioning, 2018
Figure 04. Moderate Power of Suppliers
Figure 05. Moderate Threat of New Entrants
Figure 06. High Threat of Substitutes
Figure 07. Moderate Competitive Rivalry
Figure 08. Moderate Bargaining Power of Buyers
Figure 09. Impact Analysis
Figure 10. Australia & New Zealand Ivf With Icsi Market, 2018 & 2026 ($Million)
Figure 11. Australia & New Zealand Iui Market, 2018 & 2026 ($Million)
Figure 12. Australia & New Zealand Ivf Without Icsi Market, 2018 & 2026 ($Million)
Figure 13. Australia & New Zealand Surrogacy Market, 2018 & 2026 ($Million)
Figure 14. Australia & New Zealand Others Market, 2018 & 2026 ($Million)
Figure 15. Australia & New Zealand Fresh Non-Donor Market, 2018 & 2026 ($Million)
Figure 16. Australia & New Zealand Frozen Non-Donor Market, 2018 & 2026 ($Million)
Figure 17. Australia & New Zealand Egg And Embryo Banking Market, 2018 & 2026 ($Million)
Figure 18. Australia & New Zealand Fresh Donor Market, 2018 & 2026 ($Million)
Figure 19. Australia & New Zealand Frozen Donor Market, 2018 & 2026 ($Million)
Figure 20. Australia & New Zealand Fertility Clinics Market, 2018 & 2026 ($Million)
Figure 21. Australia & New Zealand Hospitals Market, 2018 & 2026 ($Million)
Figure 22. Australia & New Zealand Surgical Centers Market, 2018 & 2026 ($Million)
Figure 23. Australia & New Zealand Clinical Research Institutes Market, 2018 & 2026 ($Million)
Figure 24. Mvf: Net Sales, 2016–2018 ($Million)
Figure 25. Mvf: Revenue Share By Region, 2018 (%)
Figure 26. Virtus Health: Net Sales, 2016–2018 ($Million)
Figure 27. Virtus Health: Revenue Share By Segment, 2018 (%)
Figure 28. Virtus Health: Revenue Share By Region, 2018 (%)